GRISENDI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 8.628
EU - Europa 4.034
AS - Asia 1.337
SA - Sud America 15
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 14.034
Nazione #
US - Stati Uniti d'America 8.590
IT - Italia 1.476
GB - Regno Unito 1.049
SE - Svezia 493
SG - Singapore 455
CN - Cina 432
DE - Germania 362
HK - Hong Kong 191
UA - Ucraina 138
FI - Finlandia 118
TR - Turchia 112
FR - Francia 107
BG - Bulgaria 76
ID - Indonesia 55
BE - Belgio 46
IE - Irlanda 37
CA - Canada 26
CZ - Repubblica Ceca 19
IN - India 19
RU - Federazione Russa 18
VN - Vietnam 18
NL - Olanda 17
AU - Australia 14
CH - Svizzera 14
IR - Iran 13
LT - Lituania 13
AL - Albania 12
BZ - Belize 12
MY - Malesia 12
RO - Romania 11
JP - Giappone 10
ES - Italia 9
BR - Brasile 6
KR - Corea 6
IL - Israele 5
MT - Malta 5
RS - Serbia 5
CL - Cile 4
AR - Argentina 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
PK - Pakistan 2
PL - Polonia 2
PT - Portogallo 2
BD - Bangladesh 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
HU - Ungheria 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 14.034
Città #
Fairfield 1.344
Southend 798
Chandler 745
Woodbridge 696
Ashburn 653
Houston 596
Seattle 474
Santa Clara 466
Cambridge 437
Ann Arbor 422
Wilmington 409
Singapore 359
Nyköping 346
Dearborn 262
Jacksonville 250
Modena 243
Hong Kong 180
New York 143
San Diego 128
Bologna 125
Beijing 110
Princeton 84
Milan 80
Helsinki 79
Sofia 76
Izmir 75
Fremont 63
Munich 62
Eugene 58
Jakarta 55
London 52
Shanghai 50
Frankfurt am Main 49
Parma 49
Boardman 43
Brussels 43
Bremen 42
Rome 41
Dublin 33
San Giuliano Milanese 31
Falls Church 30
Redwood City 26
Reggio Emilia 26
Phoenix 24
Grafing 23
Ravenna 21
Norwalk 20
Des Moines 18
Dong Ket 16
Brno 15
Ottawa 14
Napoli 13
Belize City 12
Dallas 12
Guangzhou 12
Verona 12
Bari 11
Casalecchio Di Reno 11
Ferrara 11
Mountain View 11
Genoa 10
Los Angeles 10
Paris 10
San Jose 10
Amsterdam 9
Nanjing 9
Padova 9
San Mateo 9
Segrate 9
Tulsa 9
Hefei 8
Hounslow 8
Piacenza 8
Tirana 8
Chicago 7
Las Vegas 7
Leawood 7
Romola 7
Shenyang 7
Toronto 7
Vicenza 7
Buffalo 6
Fidenza 6
Fort Worth 6
Kunming 6
Mercedes 6
Monselice 6
Romainville 6
Roncoferraro 6
Salerno 6
Valsamoggia 6
Acton 5
Albuquerque 5
Aversa 5
Changsha 5
Chiswick 5
Kilburn 5
Monmouth Junction 5
Pavia 5
Pianella 5
Totale 10.869
Nome #
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish 360
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 310
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 301
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 296
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 279
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 268
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 268
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 264
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 262
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 259
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 254
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 244
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 232
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 229
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro 228
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 227
Tumor Stroma Manipulation By MSC 225
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 224
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 218
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 217
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 214
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 214
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 213
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 208
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 203
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 200
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 195
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 195
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 190
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 190
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 183
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 182
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 181
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 181
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 181
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 175
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 171
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 170
Detection of microparticles from human red blood cells by multiparametric flow cytometry 168
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 166
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 166
GD2 CAR T cells against human glioblastoma 164
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 162
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 159
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 158
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma 155
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 154
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells 151
IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation 147
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 147
An adoptive immuno-gene therapy approach targeting neuroblastoma. 146
Sarcomas as a mise en abyme of Mesenchymal Stem Cells; exploiting interrelationships for cell mediated anticancer therapy 145
Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors 143
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review 142
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico 140
Stem cells and lung cancer : between advanced diagnostics and new therapeutics. 138
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models 137
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 136
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 135
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. 132
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 128
Challenging the efficacy of checkpoint inhibitors: a new 3D model for a precision medicine approach. 127
New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells. 127
Cancer stem cells and their microenvironment. 126
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 124
Scleral ossicles as natural biomaterials on which vascular-like network is promoted from Mouse Aortic Endothelial cells (MAECs): preliminary results 123
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 110
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 109
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 103
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 100
Refining GMP-manufactured density gradient media for optimised mesenchymal stromal/stem cell isolation and expansion. 97
Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9) 79
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 75
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine 74
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 72
Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis 68
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence 63
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 62
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro 62
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy 57
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study 54
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 48
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 47
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 45
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance 45
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 43
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 38
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 32
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 23
33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) 23
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 21
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 21
IFN-β expression is directly activated in human neutrophils transfected with plasmid DNA and is further increased via TLR-4-mediated signaling 21
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 19
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 17
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 11
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study 8
Totale 14.304
Categoria #
all - tutte 61.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.897 0 0 0 0 230 362 414 281 255 99 160 96
2020/20212.744 237 105 171 289 330 181 146 253 175 422 305 130
2021/20222.303 106 321 233 90 78 123 177 145 216 163 414 237
2022/20232.267 259 278 189 241 231 265 63 216 260 26 124 115
2023/20241.494 101 88 113 155 280 181 102 138 36 51 71 178
2024/20251.366 144 90 184 372 576 0 0 0 0 0 0 0
Totale 14.304